Skip to Content

Join the 'Psoriatic Arthropathy' group to help and get support from people like you.

Psoriatic Arthropathy News

Health Tip: Keep Psoriatic Arthritis Fatigue in Check

Posted 11 Nov 2016 by Drugs.com

-- Fatigue is a common problem for people with psoriatic arthritis. According to the National Psoriasis Foundation, some studies indicate that half of all psoriatic arthritis patients have moderate-to-severe fatigue. The Foundation suggests: Exercise regularly to help ease pain and boost energy. Eat a nutritious, well-balanced diet. Get plenty of sleep. If you have a sleep disorder, seek treatment. Prioritize your to-dos, and pace yourself throughout the week. Read more

Related support groups: Fatigue, Psoriasis, Plaque Psoriasis, Psoriatic Arthropathy

Treating Psoriasis May Reduce Risk for Other Ills

Posted 29 Jul 2016 by Drugs.com

FRIDAY, July 29, 2016 – Treating the skin disease psoriasis might reduce your risk for other health problems as well, a dermatology expert says. About 7.5 million people in the United States have the chronic skin disease. The inflammatory effects of psoriasis can affect the entire body, said Dr. Jashin Wu, director of dermatology research at Kaiser Permanente Los Angeles Medical Center. "People with psoriasis, particularly those with more severe disease, have an increased risk for a variety of other health problems, including obesity, diabetes, high blood pressure, high cholesterol, stroke and heart attack," he said in an American Academy of Dermatology news release. Psoriasis is characterized by red, raised patches of skin, or plaques, covered with silvery-white scales. It's also marked by itching, burning or soreness of the skin. It is not contagious. "Psoriasis patients, even those ... Read more

Related support groups: Obesity, High Blood Pressure, Diabetes, Type 2, Hypertension, Heart Attack, High Cholesterol, Psoriasis, Inflammatory Conditions, Insulin Resistance, Pre-Diabetes, Plaque Psoriasis, Myocardial Infarction, Diabetes Mellitus, Abnormal Glucose Tolerance, Myocardial Infarction - Prophylaxis, Psoriatic Arthropathy

New Psoriasis Drug Works Longer Term, Too

Posted 8 Jun 2016 by Drugs.com

WEDNESDAY, June 8, 2016 – A new drug that has shown "unprecedented" effects on the skin condition psoriasis seems to work well in the longer term, too, researchers report. The drug, called ixekizumab (Taltz), was approved in March by the U.S. Food and Drug Administration. That came after initial trials showed that over 12 weeks, the drug soundly beat standard medication for moderate-to-severe psoriasis. The new findings show the benefits are still there after 60 weeks. At that point, about 80 percent of patients were seeing at least a 75 percent improvement in their skin symptoms, the researchers said. So far, ixekizumab has shown "unprecedented efficacy" against more severe cases of psoriasis, said Dr. Joel Gelfand, a dermatologist who wasn't involved in the research. The drug, given by injection, targets an inflammatory protein called IL-17, said Gelfand, who directs the Psoriasis ... Read more

Related support groups: Psoriasis, Plaque Psoriasis, Taltz, Psoriatic Arthropathy

Psoriasis Tied to Obesity, Type 2 Diabetes

Posted 27 Apr 2016 by Drugs.com

WEDNESDAY, April 27, 2016 – The chronic skin disease psoriasis may be linked to excess weight and type 2 diabetes, results of a new study suggest. Danish researchers found that people with type 2 diabetes had more than 50 percent greater odds of having psoriasis compared to people without diabetes. The study also found that the rate of psoriasis went up with increasing weight. For example, obese people with a body mass index (BMI) over 35 had almost double the odds of psoriasis than normal weight people did. BMI is a body fat measurement based on height and weight. A BMI of 30 or over is considered obese. Exactly how these conditions might be connected isn't clear, but the study authors suggested that genetics, smoking, drinking alcohol, or inflammation might play a role. "Psoriasis is a complex disorder," said lead researcher Dr. Ann Sophie Lonnberg, of the University of Copenhagen. ... Read more

Related support groups: Obesity, Diabetes, Type 2, Psoriasis, Plaque Psoriasis, Psoriatic Arthropathy

Safe Treatments Available for Expectant Moms' Skin Conditions

Posted 4 Mar 2016 by Drugs.com

FRIDAY, March 4, 2016 – There are a number of safe and effective ways to treat chronic skin conditions in pregnant women, a dermatologist says. "If there is a way to manage your skin condition without medication during pregnancy, that is the preferred option," said Dr. Jenny Eileen Murase, an assistant clinical professor of dermatology at the University of California, San Francisco. "If you have a condition that does require medication, however, a board-certified dermatologist can help you identify a treatment that's safe for both you and your baby," she added in an American Academy of Dermatology news release. The release was timed to coincide with the academy's annual meeting, which starts Friday in Washington, D.C. Eczema is the most common rash dermatologists see in pregnancy, Murase said. "Expectant mothers often see their existing eczema get worse or have a flare for the first ... Read more

Related support groups: Clindamycin, Psoriasis, Eczema, Retin-A, Epiduo, Plaque Psoriasis, Benzoyl Peroxide, Acne Treatment, Cleocin, Adapalene, Salicylic Acid, Finacea, Differin, Aczone, Compound W, Duac, Benzaclin, Duofilm, Ziana, Atralin

New Drug for Severe Form of Arthritis Shows Promise in Trial

Posted 24 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 23, 2015 – A drug recently approved for the skin condition psoriasis may also help people with a debilitating form of arthritis that attacks the spine, a new clinical trial finds. The condition, called ankylosing spondylitis, causes inflammation around the vertebrae, which can lead to chronic pain and stiffness in the back and neck – and, in some people, eventually cause some vertebrae to fuse into an immobile position. In the new trial, researchers found that a drug called secukinumab (Cosentyx) helped control symptoms in 61 percent of spondylitis patients who were given the highest dose. Experts said the results, published Dec. 24 in the New England Journal of Medicine, could open up a new option for managing spondylitis. And new options are needed, said Dr. Scott Zashin, a fellow with the American College of Rheumatology who was not involved in the study. ... Read more

Related support groups: Psoriasis, Ankylosing Spondylitis, Plaque Psoriasis, Cosentyx, Psoriatic Arthropathy

Worse Psoriasis, Less Healthy Arteries, Study Finds

Posted 8 Oct 2015 by Drugs.com

THURSDAY, Oct. 8, 2015 – The skin disorder psoriasis appears linked with artery inflammation, raising the odds for heart disease, a new study says. "As the amount of psoriasis increases, the amount of blood vessel inflammation increases," said senior investigator Dr. Nehal Mehta, a clinical investigator with the U.S. National Heart, Lung, and Blood Institute. His team also found that even mild psoriasis may indicate an increased risk for heart attack and stroke. Just one psoriasis skin patch, or plaque, "might be biologically active, causing low-grade inflammation and starting a cascade, speeding up their blood vessel disease," Mehta said. "People really should know that psoriasis is not just a cosmetic disease," he added. However, these study findings only show an association between psoriasis and blood vessel inflammation, not a direct cause-and-effect relationship, Mehta said. His ... Read more

Related support groups: Methotrexate, Psoriasis, Inflammatory Conditions, Plaque Psoriasis, Coronary Artery Disease (CAD), Soriatane, Dovonex, Tazorac, Acute Coronary Syndrome, Taclonex, Oxsoralen, Acitretin, Resorcinol, Calcipotriene, Tazarotene, Acute Coronary Syndrome - Prophylaxis, Anthralin, Vectical, Dritho-Scalp, Psoriatec

Psoriasis, Depression Often Go Hand in Hand: Study

Posted 1 Oct 2015 by Drugs.com

THURSDAY, Oct. 1, 2015 – Regardless of severity, patients with the often disfiguring skin condition psoriasis face an elevated risk for depression, new research suggests. The depression risk may be driven more by concerns about appearance than by the actual status of the skin, said study author Dr. Roger Ho, an assistant professor in the department of dermatology at New York University School of Medicine. "One small area of [psoriasis] involvement might mean a lot more to one person than an area three times the size for another person," said Ho. "I think the location of skin lesions, such as lesions in a more visible area or lesions in an area that impairs daily functioning, might play a bigger role." Between 2 percent and 4 percent of North Americans have psoriasis, Ho said. The autoimmune disorder causes red, raised patches of skin covered with silvery-white scales. These patches ... Read more

Related support groups: Depression, Major Depressive Disorder, Psoriasis, Psoriatic Arthritis, Postpartum Depression, Dysthymia, Plaque Psoriasis, Psoriatic Arthropathy

2 Experimental Drugs Offer Hope Against Psoriasis: Studies

Posted 30 Sep 2015 by Drugs.com

WEDNESDAY, Sept. 30, 2015 – Two experimental drugs show promise in treating psoriasis and a related condition, psoriatic arthritis, new studies report. The drugs, brodalumab and secukinumab (Cosentyx), represent a new approach to treatment, said Michael Siegel, director of research programs at the National Psoriasis Foundation. "These studies show how targeting parts of the immune system can have great effects, and that's really exciting for our patients," said Siegel, who wasn't involved in the research. Psoriasis, a chronic autoimmune condition, causes raised red patches of skin topped with silvery scales. These patches usually appear on the scalp, elbows, knees, face, lower back, hands and feet. Psoriatic arthritis is a form of the disease that includes joint pain, stiffness and swelling. The study findings appear in the Oct. 1 issue of the New England Journal of Medicine. In one ... Read more

Related support groups: Psoriasis, Psoriatic Arthritis, Plaque Psoriasis, Cosentyx, Secukinumab, Psoriatic Arthropathy

Ask a Question

Further Information

Related Condition Support Groups

Psoriasis